L

Lucid Diagnostics Inc
NASDAQ:LUCD

Watchlist Manager
Lucid Diagnostics Inc
NASDAQ:LUCD
Watchlist
Price: 1.47 USD 3.52% Market Closed
Market Cap: 123m USD

During the last 3 months Lucid Diagnostics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 79% over this period (open performance analysis).

The last transaction was made on Sep 26, 2023 by Lapidus Stanley (Vice Chairman of the Board of Directors and Chairman Emeritus) , who sold 14.7k USD worth of LUCD shares.

Last Transactions:
Lapidus Stanley
Vice Chairman of the Board of Directors and Chairman Emeritus
$-14.7k
Lapidus Stanley
Vice Chairman of the Board of Directors and Chairman Emeritus
$-4.9k
Lapidus Stanley
Vice Chairman of the Board of Directors and Chairman Emeritus
$-4.9k
Lapidus Stanley
Vice Chairman of the Board of Directors and Chairman Emeritus
$-29k
Pavmed Inc.
Chairman & CEO
$+8m
View All Transactions

During the last 3 months Lucid Diagnostics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 79% over this period (open performance analysis).

The last transaction was made on Sep 26, 2023 by Lapidus Stanley (Vice Chairman of the Board of Directors and Chairman Emeritus) , who sold 14.7k USD worth of LUCD shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Lucid Diagnostics Inc
Insider Trading Chart

Lucid Diagnostics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Lucid Diagnostics Inc
Last Insider Transactions

Global
Insiders Monitor

Lucid Diagnostics Inc
Glance View

Market Cap
123m USD
Industry
Health Care

Lucid Diagnostics, Inc. develops medical testing devices. The company is headquartered in New York City, New York. The company went IPO on 2021-10-14. The firm is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or reflux, that leads to esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma (EAC). Its products include EsoCheck and EsoGuard. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in an office procedure. The company consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. EsoGuard is a bisulfite-converted next generation sequencing (NGS) deoxyribonucleic acid (DNA) assay performed on surface esophageal cells collected with EsoCheck. The firm is a subsidiary of PAVmed Inc.

LUCD Intrinsic Value
2.03 USD
Undervaluation 28%
Intrinsic Value
Price
L

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top